Literature DB >> 1533427

Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly.

K M Davis1, L C Fish, D Elahi, B A Clark, K L Minaker.   

Abstract

OBJECTIVE: To develop a noninvasive clinical predictive model for acute congestive heart failure (CHF) in a frail elderly cohort using bedside clinical assessment (medical history and physical examination) and venous atrial natriuretic peptide (ANP) levels.
DESIGN: One-year prospective blinded cohort study.
SETTING: Life care facility. PARTICIPANTS: Three hundred thirty-one frail, elderly volunteers free of acute illness at study entry (mean +/- SD age, 88 +/- 7 years; 23% male, 77% female). MAIN OUTCOME MEASURE: Clinical episodes of CHF with confirmation of acute pulmonary edema by chest roentgenogram.
RESULTS: Fifteen percent of the elderly cohort developed at least one episode of CHF during the 1-year follow-up period. Those developing CHF had significantly higher mean +/- SE ANP values at study entry: 493 +/- 55 vs 207 +/- 15 pmol/L. The risk for development of CHF rose progressively with increasing ANP levels at study entry. In multivariate analysis, only two independent variables significantly predicted CHF: ANP value greater than 200 pmol/L (adjusted odds ratio [OR], 7.9; 95% confidence interval [CI], 3.2 to 19.2) and history of CHF in the previous year (adjusted OR, 7.0; 95% CI, 2.9 to 17). Stratifying the cohort by these two variables results in three CHF risk groups: 55% of the population at 3% annual risk of CHF, 37% of the population at 20% to 24% annual risk of CHF, and 8% of the population at 66% annual risk of CHF.
CONCLUSIONS: This simple clinical prediction model identifies elderly subjects at risk for CHF and allows appropriate focusing of medical resources for prevention, early detection, and treatment of this highly morbid clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533427

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

Review 1.  Neuroendocrine changes in chronic cardiac failure.

Authors:  D P Nicholls; G N Onuoha; G McDowell; J S Elborn; M S Riley; A M Nugent; I C Steele; C Shaw; K D Buchanan
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

2.  Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?

Authors:  A D Struthers
Journal:  Br Heart J       Date:  1993-11

3.  Hypoxia induces release of atrial natriuretic peptide in rat atrial tissue: a role for this peptide during low oxygen stress.

Authors:  M E Ljusegren; R G Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

4.  Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.

Authors:  A M Richards; M G Nicholls; T G Yandle; H Ikram; E A Espiner; J G Turner; R C Buttimore; J G Lainchbury; J M Elliott; C Frampton; I G Crozier; D W Smyth
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

Review 5.  Natriuretic peptides in the pathophysiology of congestive heart failure.

Authors:  H H Chen; J C Burnett
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 3.955

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.